基于全基因组关联研究与多基因风险评分的女性痛风与高尿酸血症遗传贡献分析
研究纳入台湾生物银行与中国医药大学医院的59 472名女性,开展痛风、无症状高尿酸血症(AH)与血糖正常对照的全基因组关联研究及多基因风险评分(PRS)分析。结果显示,SLC2A9等基因变异与女性痛风及AH显著相关,PRS可解释痛风约0.59%至0.89%的方差,并呈现AH率与PRS四分位评分间的剂量反应趋势。
要点
- SLC2A9等基因变异是≥50岁女性痛风的主要遗传因素。
- PRS可解释痛风约0.59%至0.89%的方差。
- AH率与PRS四分位评分间呈现剂量反应趋势。
核心结论
- SLC2A9基因变异是≥50岁女性痛风的主要遗传因素,PRS在均质选择对性状有影响的变异时能更稳健地预测痛风与AH。
研究设计与样本
- 研究纳入台湾生物银行与中国医药大学医院的痛风、AH及血糖正常对照,全部参与者分为发现队列与复制队列进行GWAS,并按50岁年龄分层,共纳入59 472名女性。
主要发现
- 共纳入59 472名女性,痛风占1.60%,AH占19.59%。
- 在≥50岁女性中,位于SLC2A9、C5orf22、CNTNAP2和GLRX5基因的6个变异是痛风的显著预测因子。
- 在<50岁女性中,仅发现X染色体上的rs147750368(SPANXN1)变异。
- 位于SLC2A9、ZNF518B、PKD2和ABCG2基因的大多数变异在两个年龄组中均与AH显著相关。
- PRS在保护性效应变异中可解释痛风约0.59%至0.89%的方差,风险变异中PRS均值为6.2倍,而AH表型中仅为1.2倍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify genetic variants and polygenic risk score (PRS) relating to female gout and asymptomatic hyperuricaemia (AH) in a genome-wide association study (GWAS). METHODS: Gout, AH and normouricemia controls were included from Taiwan biobank and China Medical University Hospital. All participants were divided into discovery and replication cohorts for GWAS. PRS was estimated according to whether the variant exhibited a protective effect on the phenotypes or not. Each cohort was separated into two groups by the age of 50 years old. RESULTS: A total of 59 472 females were enrolled, and gout and AH occupied 1.60% and 19.59%, respectively. Six variants located in genes SLC2A9, C5orf22, CNTNAP2 and GLRX5 were significantly predictors of female gout in those aged ≥50. For those aged <50 years old, only the variant rs147750368 (SPANXN1) on chromosome X was found. Most variants located in genes SLC2A9, ZNF518B, PKD2 and ABCG2 were found to be significantly related to AH in both age groups. The PRS could explain ∼0.59% to 0.89% of variance of gout in variants with protective effects, which showed 6.2 times of mean PRS in the risk variants, but only 1.2 times in the AH phenotype. Moreover, the PRS also revealed a dose-response trend between AH rates and quartile scores. CONCLUSION: The variants in gene SLC2A9 are the major genetic factors for females associated with gout in those aged ≥50. PRS can provide a more robust prediction of the gout/AH under a homogeneous selection of variants that show effects on the traits.
引用
- Lin CY, Chang YS, Liu TY, et al. Genetic contributions to female gout and hyperuricaemia using genome-wide association study and polygenic risk score analyses. Rheumatology (Oxford). 2023. PMID: 35758599. doi:10.1093/rheumatology/keac369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。